Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?

Transpl Int. 2006 Nov;19(11):881-4. doi: 10.1111/j.1432-2277.2006.00391.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alemtuzumab
  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / pharmacology*
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immune Tolerance
  • Immunosuppressive Agents / pharmacology
  • Kidney Failure, Chronic / therapy
  • Kidney Transplantation / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Immunosuppressive Agents
  • Alemtuzumab